Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges

Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by a progressive increase in pulmonary vascular resistance, ultimately leading to right heart failure and death. Throughout the past 20 years, numerous specific pharmacologic agents, including phosphodiesterase-5 inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Lajoie, Annie-Christine, Bonnet, Sebastien, Provencher, Steeve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467950/
https://www.ncbi.nlm.nih.gov/pubmed/28597774
http://dx.doi.org/10.1177/2045893217710639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467950/
https://www.ncbi.nlm.nih.gov/pubmed/28597774
http://dx.doi.org/10.1177/2045893217710639

Ejemplares similares